有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-(2-bromophenyl)-5-(1H-1,2,4-triazol-5-ylsulfanylmethyl)-1,3,4-oxadiazole | —— | C11H8BrN5OS |
|
—— | (E)-3-[5-(3-chlorophenyl)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoic acid | —— | C16H11ClN2O4S |
|
—— | N-[(1R)-1-thiophen-2-ylethyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C10H12N4OS2 |
|
—— | (E)-2-[(5-ethyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-(5-methylfuran-2-yl)prop-2-enoic acid | —— | C12H12N2O4S |
|
—— | (E)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-thiophen-2-ylprop-2-enoic acid | —— | C10H8N2O3S2 |
|
—— | 1-[(3S)-3,5-dithiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)ethanone | —— | C15H13N5OS3 |
|
—— | (E)-3-[5-(4-chlorophenyl)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoic acid | —— | C16H11ClN2O4S |
|
—— | (E)-3-[5-(dimethylamino)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoic acid | —— | C12H13N3O4S |
|
—— | (E)-3-[5-(5-chloro-2-methylphenyl)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoate | —— | C17H12ClN2O4S- |
|
—— | N-(4-fluorobenzyl)-2-(1H-1,2,4-triazol-3-ylsulfanyl)acetamide | —— | C11H11FN4OS |
|
—— | (E)-3-[5-(4-bromophenyl)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoate | —— | C16H10BrN2O4S- |
|
—— | (Z)-2-[(5-ethyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-[(4R)-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-yl]prop-2-enoic acid | —— | C17H16N4O4S |
|
—— | N-[(2R)-2-phenylpropyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C13H16N4OS |
|
—— | 1-[(3R)-3,5-dithiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)ethanone | —— | C15H13N5OS3 |
|
—— | (E)-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-(5-piperidin-1-ylfuran-2-yl)prop-2-enoate | —— | C15H16N3O4S- |
|
—— | (E)-3-[5-(4-bromophenyl)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoic acid | —— | C16H11BrN2O4S |
|
—— | (E)-3-[5-(3-chlorophenyl)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoate | —— | C16H10ClN2O4S- |
|
—— | (E)-3-[5-(4-chlorophenyl)furan-2-yl]-2-[(5-methyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoate | —— | C16H10ClN2O4S- |
|
—— | N-(1-adamantyl)-N-[(4-fluorophenyl)methyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C21H25FN4OS |
|
—— | N-[2-(cyclohexen-1-yl)ethyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C12H18N4OS |
|
—— | (E)-2-[(5-ethyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-(5-methylfuran-2-yl)prop-2-enoate | —— | C12H11N2O4S- |
|
—— | (Z)-2-[(5-ethyl-1,3,4-oxadiazol-2-yl)sulfanyl]-3-(3-methylthiophen-2-yl)prop-2-enoate | —— | C12H11N2O3S2- |
|
—— | (E)-3-[5-(azepan-1-yl)furan-2-yl]-2-[(5-ethyl-1,3,4-oxadiazol-2-yl)sulfanyl]prop-2-enoic acid | —— | C17H21N3O4S |
|
—— | 1-(1-ethyl-2,5-dimethyl-1H-pyrrol-3-yl)-2-(4H-1,2,4-triazol-3-ylsulfanyl)ethanone | —— | C12H16N4OS |
|
—— | (Z)-2-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-3-(3-methylthiophen-2-yl)prop-2-enoate | —— | C16H10ClN2O3S2- |
|
—— | 2-(4-chlorophenyl)-5-[(4H-1,2,4-triazol-3-ylsulfanyl)methyl]-1,3,4-oxadiazole | —— | C11H8ClN5OS |
|
—— | N-(1-adamantylmethyl)-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C15H22N4OS |
|
—— | N-[(1S)-1-(2-bromophenyl)ethyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C12H13BrN4OS |
|
—— | N-[(1R)-1-(4-bromophenyl)ethyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C12H13BrN4OS |
|
—— | N-[(1S)-1-(4-bromophenyl)ethyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C12H13BrN4OS |
|
—— | N-[(1S)-1-(4-ethylphenyl)ethyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C14H18N4OS |
|
—— | N-[(1R)-1-(2-bromophenyl)ethyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C12H13BrN4OS |
|
—— | N-[(1R)-1-(4-ethylphenyl)ethyl]-2-(1H-1,2,4-triazol-5-ylsulfanyl)acetamide | —— | C14H18N4OS |
|
—— | (Z)-2-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-3-[5-(dimethylamino)furan-2-yl]prop-2-enoic acid | —— | C17H14ClN3O4S |
|
—— | (Z)-2-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-3-(furan-2-yl)prop-2-enoate | —— | C15H8ClN2O4S- |
|
—— | (E)-2-(1,3-benzoxazol-2-ylsulfanyl)-3-[5-(4-methylphenyl)sulfanylfuran-2-yl]prop-2-enoate | —— | C21H14NO4S2- |
|
—— | (Z)-2-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-3-(5-methylfuran-2-yl)prop-2-enoate | —— | C16H10ClN2O4S- |
|
—— | (Z)-2-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-3-(3-methylthiophen-2-yl)prop-2-enoic acid | —— | C16H11ClN2O3S2 |
|
—— | (E)-2-(1,3-benzoxazol-2-ylsulfanyl)-3-[5-(4-methylphenyl)sulfanylfuran-2-yl]prop-2-enoic acid | —— | C21H15NO4S2 |
|
—— | (E)-2-(1,3-benzoxazol-2-ylsulfanyl)-3-(5-phenylsulfanylfuran-2-yl)prop-2-enoic acid | —— | C20H13NO4S2 |
|
—— | [(2S)-1-amino-1-oxopropan-2-yl] 2-(4-bromo-2-methylphenyl)sulfanylacetate | —— | C12H14BrNO3S |
|
—— | [(2R)-1-amino-1-oxopropan-2-yl] 2-(4-bromo-2-methylphenyl)sulfanylacetate | —— | C12H14BrNO3S |
|
—— | [2-(Ethoxycarbonylamino)-2-oxoethyl] 2-(4-bromo-2-methylphenyl)sulfanylacetate | —— | C14H16BrNO5S |
|
—— | 4-[(1R)-1-(methylamino)ethyl]-N-(3-methylsulfanylphenyl)-1,3-thiazol-2-amine | —— | C13H17N3S2 |
|
—— | 4-[(1S)-1-(methylamino)ethyl]-N-(3-methylsulfanylphenyl)-1,3-thiazol-2-amine | —— | C13H17N3S2 |
|
—— | 4-[(1S)-1-(ethylamino)ethyl]-N-(3-methylsulfanylphenyl)-1,3-thiazol-2-amine | —— | C14H19N3S2 |
|
—— | 4-[(1R)-1-(ethylamino)ethyl]-N-(3-methylsulfanylphenyl)-1,3-thiazol-2-amine | —— | C14H19N3S2 |
|
—— | 2-(2-chlorophenyl)sulfanyl-N-(2,3-dihydro-1,4-benzodioxin-6-yl)pyridine-3-carboxamide | —— | C20H15ClN2O3S |
|
—— | N-cyclopentyl-2-[2-[(4-fluorophenyl)sulfanylmethyl]-5-methoxy-4-oxopyridin-1-yl]acetamide | —— | C20H23FN2O3S |
|
—— | N-(1,3-benzodioxol-5-yl)-2-(4-methylphenyl)sulfanylpyridine-3-carboxamide | —— | C20H16N2O3S |
|